Page 5 - Lennart Hansson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lennart hansson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lennart Hansson Today - Breaking & Trending Today

Svar på insändare: "Vi har fortfarande brist på vaccin, så försök igen"

Svar på insändare: "Vi har fortfarande brist på vaccin, så försök igen"
dn.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dn.se Daily Mail and Mail on Sunday newspapers.

Lennart Hansson , Region Stockholm , Below June , பகுதி ஸ்டாக்‌ஹோல்ம் ,

Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)

Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)
News provided by
Share this article
STOCKHOLM, May 27, 2021 /PRNewswire/
The following resolutions were passed at Calliditas Therapeutics AB (publ) ( Calliditas ) annual general meeting held today, on May 27, 2021.
Adoption of income statement and balance sheet for the financial year 2020 and discharge from liability
The annual general meeting resolved to adopt the income statement and the consolidated income statement for the financial year 2020 as well as the balance sheet and consolidated balance sheet as of 31 December 2020. The members of the board of directors and the managing director were discharged from liability for the financial year 2020. ....

United States , Hilde Furberg , Elmar Schnee , Lennart Hansson , Anna Svanberg , Mikael Widell , Molly Henderson , Head Of Communications , Calliditas Therapeutics , Diane Parks , Nasdaq Stockholm , Nasdaq Global Select Market , ஒன்றுபட்டது மாநிலங்களில் , எல்மர் ஸ்ச்சிநீ , மைக்கேல் வீடேல்ல் , மாலீ ஹென்டர்சன் , தலை ஆஃப் தகவல்தொடர்புகள் , டயான் பூங்காக்கள் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் , நாஸ்டாக் உலகளாவிய தேர்ந்தெடுக்கவும் சந்தை ,

Resolutions at the Annual General Meeting in Medivir on 5 May 2021

Resolutions at the Annual General Meeting in Medivir on 5 May 2021
News provided by
Share this article
HUDDINGE, Sweden, May 5, 2021 /PRNewswire/
Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing director
The annual general meeting in Medivir Aktiebolag (publ) on 5 May 2021 resolved to approve the profit and loss accounts and balance sheets for the financial year 2020. The persons who had been board members and managing directors were discharged from liability with respect to their respective management of the company for the financial year 2020.
Appropriation of the company s profit or loss ....

Uli Hacksell , Lennart Hansson , Yilmaz Mahshid , Medivir Aktiebolag , Magnus Christensen , Helena Levander , Bengt Westermark , Bengt Julander , Nasdaq Stockholm , Small Cap , மேக்னஸ் கிறிஸ்டென்சன் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் , சிறிய தொப்பி ,

Medivir AB - Interim Report January

Financing secured to bring the MIV-818 study into the next phase
January – March
Net turnover amounted to SEK 9.9 (7.3) million.
The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -7.2 (-20.7) million. Basic and diluted earnings per share amounted to SEK -0.18 (-0.96) and SEK -0.18 (-0.96) respectively.
Cash flow from operating activities amounted to SEK -1.5 (-16.6) million.
Liquid assets and short-term investments at the end of the period amounted to SEK 269.3 (116.6) million.
Significant events during the quarter
In January the company signed an exclusive license agreement with IGM Biosciences, Inc. for birinapant. Medivir received a payment of USD 1 million after signing, which is to be followed by an additional USD 1.5 million when IGM includes birinapant in phase I clinical trials. In addition, the agreement entitles Medivir to milestone payments and royalties. ....

United Kingdom , Uli Hacksell , Lennart Hansson , Yilmaz Mahshid , Magnus Christensen , Helena Levander , Biosciences Inc , Nomination Committee , Tetralogic Pharmaceuticals Corporation , Medivir Nomination Committee , Extraordinary General Meeting , Annual General Meeting , Bengt Westermark , Interim Report January , Ubiquigent Limited , ஒன்றுபட்டது கிஂக்டம் , மேக்னஸ் கிறிஸ்டென்சன் , உயிர் அறிவியல் இன்க் , நியமனம் குழு , அசாதாரண ஜநரல் சந்தித்தல் , ஆண்டு ஜநரல் சந்தித்தல் , இடைக்கால அறிக்கை ஜனவரி ,

Notice of annual general meeting of Calliditas Therapeutics AB (publ)

Notice of annual general meeting of Calliditas Therapeutics AB (publ)
News provided by
Share this article
STOCKHOLM, April 26, 2021 /PRNewswire/
The shareholders of Calliditas Therapeutics AB (publ), Reg. No. 556659-9766, with registered office in Stockholm, are summoned to the annual general meeting on Thursday 27 May 2021.
In order to mitigate the spread of Covid-19, the Board of Directors has decided that the annual general meeting will be conducted by advance voting only, without physical presence of shareholders, proxies and third parties.
Calliditas Therapeutics welcomes all shareholders to exercise their voting rights at this annual general meeting through advance voting on the basis of temporary statutory rules, according to the procedure set out below. Information on the resolutions passed at the annual general meeting will be published on 27 May 2021, as soon as the result of the voting has been finally confirmed. ....

United States , Fredrik Johansson , Monte Carlo , Lennart Hansson , Patrik Sobocki Stiftelsen Industrifonden , Hilde Furberg , Elmar Schnee , Anna Svanberg , Mikael Widell , Molly Henderson , Swedish Companie Office , Swedish Companies , Swedish Bar Association , Remuneration Committee , Calliditas Therapeutics , Euroclear Sweden , Calliditas Therapeutic , Annual General Meeting , Patrik Sobocki , Stiftelsen Industrifonden , Spike Loy , Karl Tobieson , Diane Parks , Swedish Code , Share Awards , Vesting Date ,